Advertisement
Canada markets close in 2 hours 3 minutes

  • S&P/TSX

    21,976.23
    +90.85 (+0.42%)
     

  • S&P 500

    5,111.76
    +63.34 (+1.25%)
     

  • DOW

    38,320.66
    +234.86 (+0.62%)
     

  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     

  • CRUDE OIL

    83.91
    +0.34 (+0.41%)
     

  • Bitcoin CAD

    87,509.34
    -934.69 (-1.06%)
     

  • CMC Crypto 200

    1,330.16
    -66.37 (-4.58%)
     

  • GOLD FUTURES

    2,350.70
    +8.20 (+0.35%)
     

  • RUSSELL 2000

    2,002.92
    +21.80 (+1.10%)
     

  • 10-Yr Bond

    4.6750
    -0.0310 (-0.66%)
     

  • NASDAQ

    15,962.66
    +350.90 (+2.25%)
     

  • VOLATILITY

    15.14
    -0.23 (-1.49%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6839
    +0.0018 (+0.26%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Latest stubborn U.S. inflation reading will bring about more 'wait and see' from the Fed

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

Zacks Equity Research
·2 min read

Canopy Growth Corporation (CGC) closed the most recent trading day at $16.59, moving -0.72% from the previous trading session. This change lagged the S&P 500's daily gain of 1.1%. At the same time, the Dow added 1.18%, and the tech-heavy Nasdaq gained 1.09%.

CGC will be looking to display strength as it nears its next earnings release. On that day, CGC is projected to report earnings of -$0.29 per share, which would represent a year-over-year decline of 26.09%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $74.04 million, up 9.45% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of -$1.26 per share and revenue of $379.52 million, which would represent changes of -5% and +26.54%, respectively, from the prior year.

Any recent changes to analyst estimates for CGC should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.

ADVERTISEMENT

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 47.61% lower. CGC is currently sporting a Zacks Rank of #3 (Hold).

The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 100, which puts it in the top 40% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.